RACHEL SCHIFF to Mass Spectrometry
This is a "connection" page, showing publications RACHEL SCHIFF has written about Mass Spectrometry.
Connection Strength
0.026
-
Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. Neoplasia. 2014 May; 16(5):390-402.
Score: 0.026